Clinical Trial Update: Effects of Ospemifene on Pelvic Vascularity and Blood Flow

View source ↗

Summary

The clinical trial evaluating ospemifene's effects on pelvic vascularity and blood flow in menopause was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Ospemifene (ospemifene)

Snippet

Sponsor: University of Oklahoma | Conditions: Menopause | Status: WITHDRAWN